BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 17027106)

  • 1. Plasma von Willebrand factor and soluble E-selectin levels in stable outpatients with systolic heart failure: the Frederiksberg heart failure study.
    Chong AY; Freestone B; Lim HS; Kistorp C; Gustafsson F; Hildebrandt P; Lip GY
    Int J Cardiol; 2007 Jun; 119(1):80-2. PubMed ID: 17027106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble adhesion molecule P-selectin and endothelial dysfunction in essential hypertension: implications for atherogenesis? A preliminary report.
    Lip GY; Blann AD; Zarifis J; Beevers M; Lip PL; Beevers DG
    J Hypertens; 1995 Dec; 13(12 Pt 2):1674-8. PubMed ID: 8903631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble adhesion molecules and endothelial cell damage in HIV infected patients.
    Seigneur M; Constans J; Blann A; Renard M; Pellegrin JL; Amiral J; Boisseau M; Conri C
    Thromb Haemost; 1997 Apr; 77(4):646-9. PubMed ID: 9134636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High plasma levels of von Willebrand factor as a marker of endothelial perturbation in cirrhosis: relationship to endotoxemia.
    Ferro D; Quintarelli C; Lattuada A; Leo R; Alessandroni M; Mannucci PM; Violi F
    Hepatology; 1996 Jun; 23(6):1377-83. PubMed ID: 8675154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma concentrations of von Willebrand factor and intracellular adhesion molecule-1 for prediction of outcome after successful cardiopulmonary resuscitation.
    Geppert A; Zorn G; Delle-Karth G; Koreny M; Siostrzonek P; Heinz G; Huber K
    Crit Care Med; 2003 Mar; 31(3):805-11. PubMed ID: 12626988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased levels of the soluble adhesion molecule E-selectin in essential hypertension.
    Blann AD; Tse W; Maxwell SJ; Waite MA
    J Hypertens; 1994 Aug; 12(8):925-8. PubMed ID: 7529277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure.
    Suskin N; McKelvie RS; Burns RJ; Latini R; Pericak D; Probstfield J; Rouleau JL; Sigouin C; Solymoss CB; Tsuyuki R; White M; Yusuf S
    Eur Heart J; 2000 Aug; 21(16):1368-75. PubMed ID: 10952826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amplified biochemical activation of endothelial function in hypertension associated with moderate to severe renal failure.
    Cottone S; Mulè G; Amato F; Riccobene R; Vadalà A; Lorito MC; Raspanti F; Cerasola G
    J Nephrol; 2002; 15(6):643-8. PubMed ID: 12495277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormalities of hemorheological, endothelial, and platelet function in patients with chronic heart failure in sinus rhythm: effects of angiotensin-converting enzyme inhibitor and beta-blocker therapy.
    Gibbs CR; Blann AD; Watson RD; Lip GY
    Circulation; 2001 Apr; 103(13):1746-51. PubMed ID: 11282905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. von Willebrand factor (vWf) as a plasma marker of endothelial activation in diabetes: improved reliability with parallel determination of the vWf propeptide (vWf:AgII).
    Vischer UM; Emeis JJ; Bilo HJ; Stehouwer CD; Thomsen C; Rasmussen O; Hermansen K; Wollheim CB; Ingerslev J
    Thromb Haemost; 1998 Dec; 80(6):1002-7. PubMed ID: 9869174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of severe multiple trauma complicated by acute lung injury on endothelial cell activity].
    Siemiatkowski A; Kłoczko J; Wereszczyńska-Siemiatkowska U; Czaban SL
    Przegl Lek; 2001; 58(7-8):767-71. PubMed ID: 11769384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble P-selectin as a marker of platelet hyperactivity in patients with chronic obstructive pulmonary disease.
    Ferroni P; Basili S; Martini F; Vieri M; Labbadia G; Cordova C; Alessandri C; Gazzaniga PP
    J Investig Med; 2000 Jan; 48(1):21-7. PubMed ID: 10695266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble P-selectin in atherosclerosis: a comparison with endothelial cell and platelet markers.
    Blann AD; Lip GY; Beevers DG; McCollum CN
    Thromb Haemost; 1997 Jun; 77(6):1077-80. PubMed ID: 9241735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent increase in plasma thrombomodulin in patients with a history of lupus nephritis: endothelial cell activation markers.
    Frijns R; Fijnheer R; Schiel A; Donders R; Sixma J; Derksen R
    J Rheumatol; 2001 Mar; 28(3):514-9. PubMed ID: 11296951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic clotting activation by low-grade endotoxaemia in liver cirrhosis: a potential role for endothelial procoagulant activation.
    Ferro D; Basili S; Lattuada A; Mantovani B; Bellomo A; Mannucci PM; Violi F
    Ital J Gastroenterol Hepatol; 1997 Oct; 29(5):434-40. PubMed ID: 9494853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated circulating E-selectin, intercellular adhesion molecule 1, and von Willebrand factor in patients with severe infection.
    Kayal S; Jaïs JP; Aguini N; Chaudière J; Labrousse J
    Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):776-84. PubMed ID: 9517590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Plasma levels of basal beta-endorphin and after effort in patients with severe left ventricular dysfunction and heart failure].
    Perna GP; Modoni S; Valle G; Stanislao M; de Luca G; Fanelli R; Loperfido F
    G Ital Cardiol; 1994 Sep; 24(9):1077-85. PubMed ID: 7995489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistently elevated levels of von Willebrand factor antigen in HIV infection. Downregulation during highly active antiretroviral therapy.
    Aukrust P; Bjørnsen S; Lunden B; Otterdal K; Ng EC; Ameln W; Ueland T; Müller F; Solum NO; Brosstad F; Frøland SS
    Thromb Haemost; 2000 Aug; 84(2):183-7. PubMed ID: 10959687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial haemostatic factors are associated with progression of urinary albumin excretion in clinically healthy subjects: a 4-year prospective study.
    Clausen P; Feldt-Rasmussen B; Jensen G; Jensen JS
    Clin Sci (Lond); 1999 Jul; 97(1):37-43. PubMed ID: 10369792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute rejection before cytomegalovirus infection enhances von Willebrand factor and soluble VCAM-1 in blood.
    Kas-Deelen AM; Harmsen MC; De Maar EF; Oost-Kort WW; Tervaert JW; Van Der Meer J; Van Son WJ; The TH
    Kidney Int; 2000 Dec; 58(6):2533-42. PubMed ID: 11115088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.